Roche projects mid-single digit group sales growth in 2025, with core EPS growth in the high-single digit range. The company expects a CHF1.2 billion impact from the loss of exclusivity but aims to ...
Key market drivers of the Insulin Pen and Pump market include the rising prevalence of diabetes, advancements in insulin delivery technologies ...
We think Roche's drug portfolio and industry-leading diagnostics conspire to create maintainable competitive advantages. As the market leader in both biotech and diagnostics, this Swiss healthcare ...
2-Year U.S. Treasury Note Continuous Contract $102.871 0.027 0.03% 5-Year U.S. Treasury Note Continuous Contract $106.578 0.141 0.13% 10-Year U.S. Treasury Note Continuous Contract $109.188 0.234 ...